Mon. 13 May 2024, 8:18am ET
Benzinga
Earnings, Earnings Beats, News
Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(1.05) by 25.71 percent. This is a 2.63 percent decrease over losses of $(0.76) per share from the same period last year.